TY - JOUR
T1 - Histopathological diagnosis of Japanese spotted fever using formalin-fixed, paraffin-embedded skin biopsy specimens
T2 - Usefulness of immunohistochemistry and real-time PCR analysis Tamakuma et al. Histopathological diagnosis of Japanese spotted fever
AU - Tamakuma, K.
AU - Mizutani, Y.
AU - Ito, M.
AU - Shiogama, K.
AU - Inada, K.
AU - Miyamoto, K.
AU - Utsunomiya, H.
AU - Mahara, F.
AU - Tsutsumi, Y.
N1 - Funding Information:
The excellent technical assistance given by Ms Mika Maeshima and Ms Hisayo Ban, Department of Pathology, Fujita Health University School of Medicine, Toyoake, is cordially appreciated. The authors also deeply thank Dr Hiromi Fujita, Ohara Research Laboratory, Fukushima, for providing us with strains of R. japonica and O. tsutsugamushi and also for performing serological assays. Dr Yosaburo Oikawa, Department of Parasitology, Kanazawa Medical University, Kanazawa, kindly supplied us with mouse monoclonal antibodies S3 and X1. Professor Shigeru Akimoto, Department of Microbiology, Wakayama Medical University, Wakayama, allowed us to use the biosafety level 3 facility. Professor Yasuo Chinzei, Faculty of Medical Engineering, Suzuka University of Medical Science, Suzuka, Mie, Dr Yuji Morita, Myojin Clinic, Kozagawa, Wakayama, and Dr Naoki Yakushiji, Department of Dermatology, Uwajima Municipal Hospital, Uwajima, Ehime, kindly sent us clinical samples. Dr Hidehisa Horiguchi, Pathology Division, Hyogo Prefectural Awaji Hospital, Sumoto, Hyogo, provided us with an autopsy case. Dr Toshio Kishimoto, Okayama Prefectural Institute for Environmental Science and Public Health, Okayama, cooperatively gave us valuable advice and suggestions. Dr Olivier Aoun, Bégin Military Hospital, Saint-Mandé, France, critically reviewed the manuscript. This work was supported by the Research Grant (#19590460 to F.M.) and Open Research Center Project (#30131 to Y.T.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and also by the Research Grant for Emerging and Re-emerging Infections from the Ministry of Health and Welfare, Japan (#H18-Shinko-14, H21-Shinko-6 to Y.T.). The Research Grant from Fujita Health University (2007–2010 to K.I.) also in part supported this work.
PY - 2012/3
Y1 - 2012/3
N2 - Japanese spotted fever (JSF) is caused by Rickettsia japonica, and lethal cases are reported yearly in southwest Japan. We thus established the method of diagnosing JSF by immunohistochemistry (IHC) and real-time PCR (RT-PCR) using formalin-fixed, paraffin-embedded skin biopsy specimens. Two monoclonal antibodies were used for IHC, and the 17k genus common antigen gene served as the target of RT-PCR. We collected skin biopsy (n=61) and autopsy (n=1) specimens from 50 patients clinically suspected of JSF. Immunohistochemically, the rickettsial antigens were localized as coarse dots in the cytoplasm of endothelial cells and macrophages. Thirty-one seropositive cases plus one autopsy case (group A) and nine seronegative cases but with positive IHC and/or RT-PCR (group B) were judged as JSF. Nine cases were regarded as non-JSF disorders based on negative serology, IHC and RT-PCR (group C). Of 50 biopsies (eschar 34, eruptions 10, and scabs 6) from groups A and B, IHC and RT-PCR positivities were 94% (32/34) and 62% (21/34) for eschar, 80% (8/10) and 30% (3/10) for eruptions, and 33% (2/6) and 50% (3/6) for scabs. For IHC, eschar was most suitable, and scabs were insufficient. Unexpectedly, 18 biopsies happened to be fixed in 100% formalin, and this lowered the detection rate by RT-PCR, but IHC was tolerant. Sequence analysis using five skin biopsy specimens confirmed a 114bp DNA stretch homologous to that reported for the target gene of R. japonica. In 26 (84%) of the 31 seropositive patients, the diagnosis was made by IHC and/or RT-PCR earlier than serology.
AB - Japanese spotted fever (JSF) is caused by Rickettsia japonica, and lethal cases are reported yearly in southwest Japan. We thus established the method of diagnosing JSF by immunohistochemistry (IHC) and real-time PCR (RT-PCR) using formalin-fixed, paraffin-embedded skin biopsy specimens. Two monoclonal antibodies were used for IHC, and the 17k genus common antigen gene served as the target of RT-PCR. We collected skin biopsy (n=61) and autopsy (n=1) specimens from 50 patients clinically suspected of JSF. Immunohistochemically, the rickettsial antigens were localized as coarse dots in the cytoplasm of endothelial cells and macrophages. Thirty-one seropositive cases plus one autopsy case (group A) and nine seronegative cases but with positive IHC and/or RT-PCR (group B) were judged as JSF. Nine cases were regarded as non-JSF disorders based on negative serology, IHC and RT-PCR (group C). Of 50 biopsies (eschar 34, eruptions 10, and scabs 6) from groups A and B, IHC and RT-PCR positivities were 94% (32/34) and 62% (21/34) for eschar, 80% (8/10) and 30% (3/10) for eruptions, and 33% (2/6) and 50% (3/6) for scabs. For IHC, eschar was most suitable, and scabs were insufficient. Unexpectedly, 18 biopsies happened to be fixed in 100% formalin, and this lowered the detection rate by RT-PCR, but IHC was tolerant. Sequence analysis using five skin biopsy specimens confirmed a 114bp DNA stretch homologous to that reported for the target gene of R. japonica. In 26 (84%) of the 31 seropositive patients, the diagnosis was made by IHC and/or RT-PCR earlier than serology.
UR - http://www.scopus.com/inward/record.url?scp=84857645706&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857645706&partnerID=8YFLogxK
U2 - 10.1111/j.1469-0691.2011.03569.x
DO - 10.1111/j.1469-0691.2011.03569.x
M3 - Article
C2 - 21668575
AN - SCOPUS:84857645706
SN - 1198-743X
VL - 18
SP - 260
EP - 267
JO - Clinical Microbiology and Infection
JF - Clinical Microbiology and Infection
IS - 3
ER -